Deborah Knobelman Senti Biosciences, Inc. (SNTI) insider trading activity

SNTI Quotes by TradingView

Deborah Knobelman is Chief Financial Officer of Senti Biosciences, Inc.. Currently has a direct ownership of 131,000 shares of SNTI, which is worth approximately $286,890. The most recent transaction as insider was on Feb 01, 2024, when has been sold 101,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 131K
0% 3M change
336.67% 12M change
Total Value Held $286,890

DEBORAH KNOBELMAN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 01 2024
BUY
Grant, award, or other acquisition
-
101,000 Added 43.53%
131,000 Common Stock
Oct 03 2022
BUY
Grant, award, or other acquisition
-
30,000 Added 50.0%
30,000 Common Stock

Also insider at

KRON
Kronos Bio, Inc. Healthcare
Chief Financial Officer
DK

Deborah Knobelman

Chief Financial Officer
South San Francisco, CA

Track Institutional and Insider Activities on SNTI

Follow Senti Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SNTI shares.

Notify only if

Insider Trading

Get notified when an Senti Biosciences, Inc. insider buys or sells SNTI shares.

Notify only if

News

Receive news related to Senti Biosciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SNTI